Skip to main content

Together we are beating cancer

Donate now

Breast cancer

Breast cancer is the most common cancer in the UK, with around 55,200 people diagnosed each year. It starts in the breast tissue, most commonly in cells lining the milk ducts. Breast cancer predominantly affects women, but men can get it too.
Showing 12 out of 634 results
Cancer Research UK logo

Cancer Research UK has started recruiting patients for a pioneering initiative to demonstrate how genetic tests could be used within the NHS to help match cancer patients to the most appropriate treatment, while building a database of information for research into new targeted therapies. Cancer Research UK has started recruiting patients for a pioneering initiative to demonstrate how genetic tests could be used within the NHS to help match cancer patients to the most appropriate treatment, while building a database of information for research into new targeted therapies.

by Cancer Research UK | News | 21 November 2011

21 November 2011

Unravelling the genetic secrets behind a range of cancers is the aim of a new initiative from Cancer Research UK. Unravelling the genetic secrets behind a range of cancers is the aim of a new initiative from Cancer Research UK.

by Cancer Research UK | News | 18 November 2011

18 November 2011

Cancer Research UK logo

Fear, anxiety and embarrassment are some of the main barriers preventing women from going for breast screening, but this alone does not account for the variations in uptake, according to new work presented today at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool today (Wednesday). Fear, anxiety and embarrassment are some of the main barriers preventing women from going for breast screening, but this alone does not account for the variations in uptake, according to new work presented today at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool today (Wednesday).

by The National Cancer Research Institute (NCRI) | News | 9 November 2011

9 November 2011

Cancer Research UK logo

A class of drugs used to treat breast cancers which overproduce a protein called HER2 could also treat other types of cancer - particularly head and neck cancers, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool this week. A class of drugs used to treat breast cancers which overproduce a protein called HER2 could also treat other types of cancer - particularly head and neck cancers, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool this week.

by The National Cancer Research Institute (NCRI) | News | 9 November 2011

9 November 2011

Cancer Research UK logo

Women may not receive adequate information on fertility preservation before breast cancer treatment, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool today (Monday). Women may not receive adequate information on fertility preservation before breast cancer treatment, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool today (Monday).

by The National Cancer Research Institute (NCRI) | News | 7 November 2011

7 November 2011

Cancer Research UK logo

THE NHS must start planning now to deal with a predicted leap of 45 per cent in the number of new cancer cases in the UK over the next two decades, Cancer Research UK warns today. THE NHS must start planning now to deal with a predicted leap of 45 per cent in the number of new cancer cases in the UK over the next two decades, Cancer Research UK warns today.

by Cancer Research UK | News | 28 October 2011

28 October 2011

Cancer Research UK logo

CANCER RESEARCH UK scientists have discovered that switching off a gene called CERT makes breast cancer cells more sensitive to a range of drugs. CANCER RESEARCH UK scientists have discovered that switching off a gene called CERT makes breast cancer cells more sensitive to a range of drugs.

by Cancer Research UK | News | 20 October 2011

20 October 2011

Cancer Research UK logo

Cancer Research UK scientists are investigating whether beta-blockers hold the key to preventing breast cancer spread and improving survival. Promising early results will be presented on the eve of breast cancer awareness month at the Royal Society of Medicine, today. Cancer Research UK scientists are investigating whether beta-blockers hold the key to preventing breast cancer spread and improving survival. Promising early results will be presented on the eve of breast cancer awareness month at the Royal Society of Medicine, today.

by Cancer Research UK | News | 30 September 2011

30 September 2011